A panel of 1,1-(phenylene)bis[3-chloro-4-(substituted phenyl)azetidin-2-ones] (4a-m) and 3,3′-(1,4-phenylene)bis[2-(substituted phenyl)thiazolidin-4-ones] (5a-m) were synthesized from Schiff base intermediates 3a-m, that were in turn prepared from reaction between p-phenylenediamine and substituted benzaldehydes. The structures of title compounds and intermediates were confirmed by IR, 1H NMR, 13C NMR and mass spectral data. The compounds were screened for antibacterial, DPPH radical scavenging and antidiabetic activities. Compounds 4f and 4a exhibited good antibacterial activity against Gram-positive bacteria, but none showed appreciable activity against Gram-negative bacteria. In DPPH scavenging assay, compounds 5f, 5e and 5a exhibited good activity. Compound 5a displayed highly significant antidiabetic activity in fructose-induced diabetes in rats. The molecular docking studies of bis-thiazolidinones with PPAR-ã revealed the fit with high binding affinity and good interactions. Docking of compound 5a was comparable to the standard drug pioglitazone. The in silico physicochemical, drug-likeness and ADME properties of title compounds were also performed and the majority of them displayed satisfactory results.
Similar content being viewed by others
References
http://www.statista.com/topic/1723/diabetes (Last accessed 05-03-2020).
P. F. Valeron, P. L. Velasco, Med. Clin. (Barc.), 141(2), 20 – 25 (2013).
M. R. Bhosle, J. R. Mali, S. Pal, et al., Bioorg. Med. Chem. Lett., 24(12), 2651 – 2654 (2014).
R. Bhutani, D. P. Pathak, G. Kapoor, et al., Bioorg. Chem., 83(2), 6 – 19 (2019).
S. Asghari, M. Pourshab, M. Mohseni, Monatsh für Chemie, 149(12), 2327 – 2336 (2018).
M. Omar, H. H. Abdu-Allah, S. G. Abdel-Moty, Bioorg. Chem., 80, 461 – 471 (2018).
F. Ansari, D. Idrees, M. I. Hassan, et al., Eur. J. Med. Chem., 144, 544 – 556 (2018).
O. Guzel, A. Salman, J. Enz. Inhib. Med. Chem., 24(4), 1015 – 1023 (2009).
Mishchenko, S. Shtrygol, D. Kaminskyy, et al., Scientia Pharm., 88(1), 16 (2020).
D. Patel, P. Kumari, N. Patel, Eur. J. Med. Chem., 48, 354 – 362 (2012).
N. Arya, A. Y. Jagdale, T. A. Yeramwar, et al., Eur. J. Med. Chem., 74, 619 – 656 (2014).
I. K. Bhat, S. K. Chaithanya, P. D. Satyanarayana, et al., J. Serb. Chem. Soc., 72(5), 437 – 442 (2007).
A. Deep, P. Kumar, B. Narasimhan, et al., Pharm. Chem. J., 50(1), 24 – 28 (2016).
R. J. Shah, N. R. Modi, M. J. Patel, et al., Med. Chem. Res., 20(5), 587 – 594 (2011).
N. B. Patel, K. K. Pathak, Med. Chem. Res., 21(8), 2044 – 2055 (2012).
N. H. Chopde, J. S. Meshram, C. P. Pandhurnekar, et al., J. Heterocycl. Chem., 53(3), 824 – 831 (2016).
H. Hasan, M. Akhter,W. Akhter, et al., Med. Chem. Res., 20(8), 1357 – 1363 (2010).
S. K. Bhati, A. Kumar, Eur. J. Med. Chem., 43(11), 2323 – 2330 (2008).
R. Geesala, J. K. Gangasani, M. Budde, et al., Eur. J. Med. Chem., 124, 544 – 558 (2016).
Q. C. Ren, C. Gao, Z. Xu, et al., Curr. Top. Med. Chem., 18(2), 101 – 113 (2018).
S. Alpan, S. Zencir, I. Zupkó, et al., J. Enz. Inhib. Med. Chem., 24(3), 844 – 889 (2009).
Y. N. Mabkhot, A. Barakat, A. M. Al-Majid, et al., Chem. Cent. J., 7, 112 – 120 (2013).
M. Mielczarek, R. V. Devakaram, C. Ma, et al., Org. Biomol. Chem., 12, 2882 – 2894 (2014).
V. S. Ramya, M. H. Kallappa, S. K. Rangappa, et al., Eur. J. Med. Chem., 45(5), 1753 – 1759 (2010).
P. Patel, S. Korgaokar, K. Parekh, et al., Indian J. Chem., 38(B), 696 – 700 (1999).
S. Sankar, K. Divya, A. Padmaja, et al., Med. Chem., 7(11), 340 – 347 (2017).
S. F. Barbuceaunu, D. C. Ilies, G. Saramet, et al., Int. J. Mol. Sci., 15(6), 10908 – 10925 (2014).
OECD Guidelines-425 for the testing of chemicals 2008. https://www.oecd-ilibrary.org/environment/test-no-425-acuteoral-toxicity-up-and-down-procedure9789264071049-en (Last accessed 08-05-2020).
M. O. Germoush, H. A. Elgebaly, S. Hassan, A. M. Mahmoud, Aljouf Sci. Eng. J., 286(3104), 1 – 7 (2015).
M. J. Medina, J. Bartroli, J. Alonso, et al., Anal. Lett., 17(5), 385 – 396 (1984).
https://www.rcsb.org/structure/4PRG (Last accessed 16-07-2021).
G. M. Morris, R. Huey, W. Lindstrom, et al., J. Comput. Chem., 16(30), 2785 – 2791 (2009).
D. Hanwell, D. E. Curtis, D. C. Lonie, et al., J. Cheminform., 4(1), 1 – 7 (2012).
D. S. Biovia, Discovery studio modeling environment dassault systems, San Diego, USA (2021).
http://www.swissadme.ch/ (Last accessed on18-07-2021).
M. Lehrke, M. A. Lazar, Cell, 123(6), 9939 (2005).
J. H. Kim, J. Song, K. W. Park, Arch. Pharmacol. Res., 38(3), 302 – 312 (2015).
A. Abdul-Ghani, D. Tripathy, R. A. DeFronzo, Diab. Care, 29(5), 1130 – 1139 (2006).
C. A. Lipinski, F. Lombardo, B. W. Dominy, et al., Adv. Drug Deliver. Rev., 23(1 – 3), 3 – 25 (1997).
A. K. Ghose, V. N. Viswanadhan, J. J. Wendoloski, J. Combi Chem., 1(1), 55 – 68 (1999).
D. F. Veber, S. R. Johnson, H. Y. Cheng, et al., J. Med. Chem., 45(12), 2615 – 2623 (2002).
W. J. Egan, K. M. Merz, J. J. Baldwin, J. Med. Chem., 43(21), 3867 – 3877 (2000).
I. Muegge, S. L. Heald, D. Brittelli, J. Med. Chem., 44(12), 1841 – 1886 (2001).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Deshpande, S.R., Mandalamari, M.T., Malagi, P.V. et al. Synthesis, In Silico Analysis, Antibacterial, Radical Scavenging and Antidiabetic Activities of Certain Bis-Azetidinones and Bis-Thiazolidinones. Pharm Chem J (2024). https://doi.org/10.1007/s11094-024-03119-9
Received:
Published:
DOI: https://doi.org/10.1007/s11094-024-03119-9